Vascular Solutions Inc. (Nasdaq:VASC) reported financial results for the first quarter ended March 31, 2011. Net revenue for the first quarter was $21.3 million, at the high end of the guidance previously provided by the company and an increase of 17% from the first quarter of 2010. U.S. net revenue increased by 15% while international net revenue increased by 27% from the first quarter of 2010. Net earnings for the first quarter was $1.7 million ($0.10 per diluted share), also at the high end of the company’s guidance, compared to net earnings for the first quarter of 2010 of $3.5 million ($0.21 per diluted share). In the first quarter of 2010 the company recorded a $3.5 million litigation gain ($0.13 per diluted share) as the result of payment received in its litigation with Marine Polymer Technologies, Inc. Excluding the litigation gain, net earnings in the first quarter of 2011 increased by 35% over the first quarter of 2010.
Vascular Solutions, Inc., a medical device company, develops solutions to interventional cardiologists and interventional radiologists worldwide. The company was founded in 1996 and is based in Minneapolis, Minnesota.
Power3 Medical Products, Inc (PWRME)
Parkinson’s disease affects the way you move. It happens when there is a problem with certain nerve cells in the brain.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Normally, these nerve cells make an important chemical called dopamine. Dopamine sends signals to the part of your brain that controls movement. It lets your muscles move smoothly and do what you want them to do. When you have Parkinson’s, these nerve cells break down. Then you no longer have enough dopamine, and you have trouble moving the way you want to.
Parkinson’s is progressive, which means it gets worse over time. But usually this happens slowly, over a period of many years. And there are good treatments that can help you live a full life.
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro�, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro�, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Power3 Medical is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
1) Breast Cancer 5) Chemotherapeutic Drug Resistance
2) Alzheimer’s Disease 6) Leukemia
3) ALS (Lou Gehrig’s Disease) 7) Gastrointestinal Disease
4) Parkinson’s Disease 8)Metabolic Syndrome
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
Big 5 Sporting Goods Corp. (Nasdaq:BGFV) a leading sporting goods retailer, will announced first quarter fiscal 2011 financial results on Tuesday, May 3, 2011, after the market close. The Company also will hold a conference call and audio webcast to discuss these results and provide additional comments and details. The conference call and audio webcast is scheduled to begin at 2:00 p.m. Pacific (5:00 p.m. EDT) on May 3, 2011. The webcast also will be broadcast live over the Internet at www.big5sportinggoods.com. The webcast will be archived and accessible on the same website for 30 days following the call. Visitors to the website should select the “Investor Relations” link to access the webcast.
Big 5 Sporting Goods Corporation, together with its subsidiaries, engages in the retail of sporting goods in the western United States. The company was founded in 1955 and is headquartered in El Segundo, California.
NewStar Financial, Inc. (Nasdaq:NEWS) announced that it will report results for the first quarter of 2011 on Wednesday, May 4, 2011 before the markets open. NewStar will also host a webcast/conference call to discuss the results on Wednesday, May 4, 2011 at 10:00am Eastern Time. All interested parties are invited to participate via telephone or webcast, which will be hosted through the Investor Relations section of the website at www.newstarfin.com. Please visit the website to register for the webcast and test your connection prior to the call. You can also access the conference call by dialing 877-755-7419 approximately 5-10 minutes prior to the call. International callers should dial 973-200-3080. All callers should reference “NewStar Financial.”
NewStar Financial, Inc., a commercial finance company, provides customized debt financing solutions in the United States. The company principally focuses on the direct origination of loans and other debt products.
No comments:
Post a Comment